Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
The effectiveness of a new levo-norgestrel releasing intrauterine device is assessed in fourteen patients with histologically confirmed hyperplastic lesions of the endometrial mucosa. The morphologic response of the hyperplastic endometria to the action of the levo-norgestrel in this study explains the regression of the cases so treated.
D000328:Adult; D004714:Endometrial Hyperplasia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D016912:Levonorgestrel; D008875:Middle Aged; D009644:Norgestrel / Q000008:administration & dosage*
D009644:Norgestrel; D016912:Levonorgestrel